Clinical Trial Update: Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms [Phase 4]

View source ↗

Summary

A placebo-controlled Phase 4 trial evaluating rotigotine for non-motor symptoms in idiopathic Parkinson's disease has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-05-09